VIMAX | VYMRX | VIMAX / VYMRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 23 years | 26 years | - |
Gain YTD | 16.191 | 16.017 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 1000 | 300% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 176B | 177M | 99,435% |
Annual Yield % from dividends | 1.49 | 0.36 | 417% |
Returns for 1 year | 28.62 | 29.11 | 98% |
Returns for 3 years | 9.74 | -4.48 | -217% |
Returns for 5 years | 62.59 | 35.06 | 178% |
Returns for 10 years | 147.06 | 6.40 | 2,299% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TSLL | 9.69 | 0.14 | +1.47% |
Direxion Daily TSLA Bull 2X Shares | |||
JSMD | 73.80 | 0.42 | +0.57% |
Janus Henderson Small/Md Cp Gr Alpha ETF | |||
IWFL | 43.97 | 0.15 | +0.34% |
ETRACS 2x Leveraged US Gr Fctr TR ETN | |||
BSMS | 23.55 | 0.04 | +0.17% |
Invesco BulletShares (R) 2028MuncplBdETF | |||
BIS | 14.57 | -0.32 | -2.15% |
ProShares UltraShort Nasdaq Biotech |